The spatial RNA integrity number assay for in situ evaluation of transcriptome quality.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
08 01 2021
Historique:
received: 21 01 2020
accepted: 11 11 2020
entrez: 9 1 2021
pubmed: 10 1 2021
medline: 3 7 2021
Statut: epublish

Résumé

The RNA integrity number (RIN) is a frequently used quality metric to assess the completeness of rRNA, as a proxy for the corresponding mRNA in a tissue. Current methods operate at bulk resolution and provide a single average estimate for the whole sample. Spatial transcriptomics technologies have emerged and shown their value by placing gene expression into a tissue context, resulting in transcriptional information from all tissue regions. Thus, the ability to estimate RNA quality in situ has become of utmost importance to overcome the limitation with a bulk rRNA measurement. Here we show a new tool, the spatial RNA integrity number (sRIN) assay, to assess the rRNA completeness in a tissue wide manner at cellular resolution. We demonstrate the use of sRIN to identify spatial variation in tissue quality prior to more comprehensive spatial transcriptomics workflows.

Identifiants

pubmed: 33420318
doi: 10.1038/s42003-020-01573-1
pii: 10.1038/s42003-020-01573-1
pmc: PMC7794352
doi:

Substances chimiques

RNA, Messenger 0

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

57

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 100308/Z/12/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12010/3
Pays : United Kingdom

Références

Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
PLoS One. 2013 Oct 23;8(10):e78480
pubmed: 24194939
Science. 2016 Jul 1;353(6294):78-82
pubmed: 27365449
Sci Rep. 2016 Nov 16;6:37137
pubmed: 27849009
Bioinformatics. 2017 Aug 15;33(16):2591-2593
pubmed: 28398467
Commun Biol. 2021 Jan 8;4(1):57
pubmed: 33420318
BMC Res Notes. 2016 Jan 07;9:17
pubmed: 26744212
Nat Methods. 2013 Sep;10(9):857-60
pubmed: 23852452
Nucleic Acids Res. 2011 May;39(9):e63
pubmed: 21317187
Nat Protoc. 2015 Mar;10(3):442-58
pubmed: 25675209
Environ Health Toxicol. 2014 Sep 11;29:e2014007
pubmed: 25234413
BMC Biol. 2014 May 30;12:42
pubmed: 24885439
PLoS One. 2013;8(3):e57521
pubmed: 23469199
Bioinformatics. 2007 May 15;23(10):1289-91
pubmed: 17379693
BMC Mol Biol. 2006 Jan 31;7:3
pubmed: 16448564
Science. 2015 Apr 24;348(6233):aaa6090
pubmed: 25858977
Science. 2019 Mar 29;363(6434):1463-1467
pubmed: 30923225
Bioinformatics. 2018 Jun 1;34(11):1966-1968
pubmed: 29360929
Nat Methods. 2014 Apr;11(4):360-1
pubmed: 24681720
Nucleic Acids Res. 2005 Mar 30;33(6):e56
pubmed: 15800207
Science. 2016 Jun 24;352(6293):1586-90
pubmed: 27339989
Science. 2016 Aug 26;353(6302):925-8
pubmed: 27471252
Nat Protoc. 2018 Nov;13(11):2501-2534
pubmed: 30353172
Nucleic Acids Res. 2012 Aug;40(15):e115
pubmed: 22730293

Auteurs

Linda Kvastad (L)

Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.

Konstantin Carlberg (K)

Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.

Ludvig Larsson (L)

Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.

Eva Gracia Villacampa (EG)

Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.

Alexander Stuckey (A)

Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.

Linnea Stenbeck (L)

Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.

Annelie Mollbrink (A)

Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.

Margherita Zamboni (M)

Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.

Jens Peter Magnusson (JP)

Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Bioengineering Department, Stanford University, Stanford, USA.

Elisa Basmaci (E)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.

Alia Shamikh (A)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.

Gabriela Prochazka (G)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.

Anna-Lena Schaupp (AL)

Nuffield Department of Clinical Neurosciences, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital University of Oxford, Oxford Centre for Neuroinflammation, Oxford, UK.

Åke Borg (Å)

Division of Oncology and Pathology, Department of Clinical Sciences, Lund Lund University, Lund, Sweden.

Lars Fugger (L)

Nuffield Department of Clinical Neurosciences, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital University of Oxford, Oxford Centre for Neuroinflammation, Oxford, UK.

Monica Nistér (M)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.

Joakim Lundeberg (J)

Science for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden. joakim.lundeberg@scilifelab.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH